The US is backing at-home HPV testing to boost cervical cancer screening by removing cost, access, and comfort barriers. Under new HRSA guidelines, women aged 30 to 65 years can use self-collected vaginal samples for HPV tests, covered by private insurance from 2027, helping close screening gaps and detect cervical cancer early.